A detailed history of Bck Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bck Partners, Inc. holds 284 shares of LLY stock, worth $225,970. This represents 0.12% of its overall portfolio holdings.

Number of Shares
284
Previous 284 -0.0%
Holding current value
$225,970
Previous $257,000 2.33%
% of portfolio
0.12%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $205,863 - $258,167
284 New
284 $257,000
Q1 2022

Apr 21, 2022

BUY
$234.69 - $291.66 $3.3 Million - $4.1 Million
14,059 New
14,059 $4.03 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bck Partners, Inc. Portfolio

Follow Bck Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bck Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bck Partners, Inc. with notifications on news.